Beiersdorf, DE0005200000

Beiersdorf confirms 2026 outlook. Beiersdorf stock falls 2.98 percent

Published on 10/27/2026 at 15:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

NIVEA sales fell 4.90 percent organically in the third quarter. Beiersdorf stock costs EUR 80.80 on October 27, 2026, 2.98 percent below Xetra close.

Beiersdorf update in three figures

Beiersdorf confirmed its 2026 outlook while third-quarter organic sales declined 1.30 percent.
NIVEA sales fell 4.90 percent organically, while Derma sales grew 10.60 percent in the third quarter.
Beiersdorf stock was at EUR 80.80 at Lang & Schwarz on October 27, 2026, down 2.98 percent versus the Xetra close of October 26, 2026.

Beiersdorf, DE0005200000, Illustration mit AI erstellt.

Beiersdorf (ISIN DE0005200000) was trading at EUR 80.80 at Lang & Schwarz on October 27, 2026, at 3:36 p.m. CEST, down 2.98 percent versus the Xetra close of October 26, 2026, at EUR 83.28. In a release dated October 27, 2026, Beiersdorf confirmed its 2026 outlook after third-quarter organic sales declined 1.30 percent.

NIVEA weakness sets the tone

The quarterly mix is the key market finding. Group sales reached EUR 2.4 billion in the third quarter, but NIVEA sales fell 4.90 percent organically. Derma sales grew 10.60 percent and La Prairie sales rose 8.50 percent organically, according to the Beiersdorf release.

The divergence matters because NIVEA remains the larger business. Beiersdorf reported NIVEA third-quarter sales of EUR 1.263 billion and Derma sales of EUR 401 million. Tesa sales fell 4.30 percent organically as semiconductor shortages affected its Electronics business, adding a second pressure point to the update.

Can Derma offset NIVEA?

The answer depends on scale as well as growth. First-nine-month group sales were EUR 7.3 billion, down 2.80 percent organically, while Consumer sales declined 2.90 percent organically. The company release shows that Derma growth is strong, but it has not yet outweighed the larger NIVEA decline at group level.

Beiersdorf kept its full-year 2026 guidance for a low-single-digit organic sales decline and an adjusted group EBIT margin of at least 11.80 percent. Consumer EBIT margin guidance remains at least 11.00 percent, while tesa margin is expected to stay slightly below the prior year because semiconductor-related mix effects may persist.

Beiersdorf stock after the update

The share price puts the operational split into market terms: a strong Derma contribution and improving NIVEA dynamics have not prevented a 2.98 percent intraday decline versus the previous Xetra session. At EUR 80.80, the stock remains inside its EUR 67.08 to EUR 110.20 52-week range as of October 27, 2026.

The further course of trading is shown by the continuously updated real-time quote of Beiersdorf stock.